California State Teachers Retirement System lowered its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 6.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,953,367 shares of the company's stock after selling 190,669 shares during the period. California State Teachers Retirement System owned approximately 0.15% of Kenvue worth $56,438,843 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Kenvue in the 2nd quarter valued at $2,882,279,000. Pentwater Capital Management LP bought a new stake in Kenvue during the 2nd quarter valued at $977,094,000. Geode Capital Management LLC grew its stake in shares of Kenvue by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company's stock valued at $856,778,000 after buying an additional 371,322 shares during the last quarter. Independent Franchise Partners LLP grew its stake in Kenvue by 56.3% in the fourth quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company's stock worth $830,527,000 after purchasing an additional 17,343,785 shares during the period. Finally, Norges Bank purchased a new stake in shares of Kenvue during the 4th quarter valued at about $756,862,000. 97.64% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
KVUE has been the subject of several research reports. Zacks Research cut shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 7th. UBS Group cut their target price on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research report on Tuesday, August 11th. Wall Street Zen downgraded shares of Kenvue from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Barclays raised their price target on shares of Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 21st. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Kenvue in a research report on Friday. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. According to MarketBeat.com, Kenvue currently has a consensus rating of "Hold" and an average target price of $19.27.
Check Out Our Latest Stock Report on Kenvue
Kenvue Trading Down 0.4%
KVUE stock traded down $0.07 during trading on Tuesday, reaching $17.84. The company had a trading volume of 37,794,643 shares, compared to its average volume of 28,124,885. The company has a market cap of $34.26 billion, a P/E ratio of 20.49, a PEG ratio of 1.59 and a beta of 0.46. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $20.13. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. The business has a 50 day moving average of $19.02 and a 200 day moving average of $18.23.
Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). The firm had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.During the same quarter last year, the business posted $0.29 EPS. Kenvue's revenue was up 3.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.
Kenvue Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 2nd. Investors of record on Monday, September 21st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend is Monday, September 21st. Kenvue's dividend payout ratio is 96.55%.
Kenvue Profile
(
Free Report)
Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.
The company's brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson's and Band-Aid in baby care and essential health.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.
